Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Peeters, Marc" or (type any "bookEditor issueEditor" and editor="Peeters, Marc")

Add to list
- Journal Article
- A1
- open access
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib

Ahmad Awada, Thierry Berghmans, Paul M. Clement, Kristof Cuppens, Bram De Wilde (UGent) , Jean-Pascal Machiels, Patrick Pauwels, Marc Peeters, Sylvie Rottey (UGent) and Eric Van Cutsem

(2022) CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 169.
Add to list
- Journal Article
- A1
- open access
Population-based data reveal factors associated with organised and non-organised colorectal cancer screening : an important step towards improving coverage

Thuy Ngan Tran, Guido Van Hal, Marc Peeters, Svetlana Jidkova (UGent) , Harlinde De Schutter and Sarah Hoeck

(2021) INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 18(16).
Add to list
A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors

Gerald S. Falchook, Marc Peeters, Sylvie Rottey (UGent) , Luc Y. Dirix, Radka Obermannova, Jonathan E. Cohen, Ruth Perets, Ronnie Shapira Frommer, Todd M. Bauer, Judy S. Wang, et al.

(2021) INVESTIGATIONAL NEW DRUGS. 39(5). p.1284-1297
Add to list
- Journal Article
- A2
- open access
Expected medium- and long-term impact of the COVID-19 outbreak in oncology

Concetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, Nadia Harbeck, Rupert Bartsch, Hans Wildiers, Vivianne Tjan-Heijnen, Miguel Martin, Sylvie Rottey (UGent) , Daniele Generali, et al.

(2021) JCO GLOBAL ONCOLOGY. 7. p.162-172
Add to list
- Journal Article
- A1
- open access
Study protocol for a randomized controlled trial : prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy (PRESTO trial)

Margot Baudelet (UGent) , Leen Van den Steen, Fréderic Duprez (UGent) , Marc De Bodt (UGent) , Sarah Deschuymer, Ann Goeleven, Isabel Hutsebaut, Steven Mariën, Sabine Meersschout, Daan Nevens, et al.

(2020) TRIALS. 21(1).
Add to list
- Journal Article
- A1
- open access
Oncological care organisation during COVID-19 outbreak

Concetta Elisa Onesti, Hope S. Rugo, Daniele Generali, Marc Peeters, Khalil Zaman, Hans Wildiers, Nadia Harbeck, Miguel Martin, Massimo Cristofanilli, Javier Cortes, et al.

(2020) ESMO OPEN. 5(4).
Add to list
- Journal Article
- A1
- open access
Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer : a post hoc analysis of two non-randomized phase II trials

Nicolas Charette, Caroline Vandeputte, Lieveke Ameye, Camille Van Bogaert, Jonathan Krygier, Thomas Guiot, Amelie Deleporte, Thierry Delaunoit, Karen Geboes (UGent) , Jean-Luc Van Laethem, et al.

(2019) BMC CANCER. 19.
Add to list
- Conference Paper
- C3
Is a single driver gene mutation sufficient for monitoring early response in advanced colorectal cancer

Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Hakim El Housni, Amelie Deleporte, Karen Geboes (UGent) , Thierry Delaunoit, Gauthier Demolin, Marc Peeters, Lionel D'Hondt, et al.

(2019) CANCER RESEARCH. 79(13, suppl.).
Add to list
Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation

Julie Jacobs, Vanessa Deschoolmeester, Karen Zwaenepoel, Tal Flieswasser, Christophe Deben, Jolien Van den Bossche, Christophe Hermans, Christian Rolfo, Marc Peeters, Olivier De Wever (UGent) , et al.

(2018) ONCOIMMUNOLOGY. 7(7).
Add to list
- Conference Paper
- C3
Effects of molecular tumor board and different NGS panels implementation for the treatment of patients with cancer

Christian Diego Rolfo, Paolo Manca, Roberto Salgado, Peter Van Dam, Amélie Dendooven (UGent) , Andreia Machado Coelho, Ferri Pep, Annemie Rutten, Willem Lybaert, Joanna Vermeij, et al.

(2018) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 36(15, Supplement S).
Add to list
- Journal Article
- A1
- open access
Multidisciplinary molecular tumour board : a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer

Christian Rolfo, Paolo Manca, Roberto Salgado, Peter Van Dam, Amélie Dendooven (UGent) , Andreia Machado Coelho, Jose Ferri Gandia, Annemie Rutten, Willem Lybaert, Joanna Vermeij, et al.

(2018) ESMO OPEN. 3(5).
Add to list
- Conference Paper
- C3
Circulating tumor DNA detects early response to regorafenib in advanced colorectal cancer

Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Hakim El Housni, Jean-Francois Laes, Amelie Deleporte, Karen Geboes (UGent) , Thierry Delaunoit, Gauthier Demolin, Marc Peeters (UGent) , et al.

(2018) CANCER RESEARCH. In Cancer Research 78(13).
Add to list
- Conference Paper
- C3
High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib

Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Hakim El Housni, Amelie Deleporte, Karen Geboes (UGent) , Thierry Delaunoit, Marc Peeters (UGent) , Gauthier Demolin, Lionel D'Hondt, et al.

(2018) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 36(15).
Add to list
- Journal Article
- A2
- open access
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor

Caroline Vandeputte, Pashalina Kehagias, Hakim El Housni, Lieveke Ameye, Jean-François Laes, Christine Desmedt, Christos Sotiriou, Amélie Deleporte, Francesco Puleo, Karen Geboes (UGent) , et al.

(2018) ONCOTARGET. 9(25). p.17756-17769
Add to list
- Journal Article
- A2
- open access
Children's International Polyposis (CHIP) study : a randomized, double-blind, placebo-controlled study of celecoxib in children with familial adenomatous polyposis

Carol A Burke, Robin Phillips, Manuela F Berger, Chunming Li, Margaret Noyes Essex, Dinu Iorga, Patrick M Lynch, the study site investigators, Catharina Dhooge (UGent) and Marc Peeters (UGent)

(2017) CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY. 10. p.177-185

Academic Bibliography

Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib

Population-based data reveal factors associated with organised and non-organised colorectal cancer screening : an important step towards improving coverage

A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors

Expected medium- and long-term impact of the COVID-19 outbreak in oncology

Study protocol for a randomized controlled trial : prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy (PRESTO trial)

Oncological care organisation during COVID-19 outbreak

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer : a post hoc analysis of two non-randomized phase II trials

Is a single driver gene mutation sufficient for monitoring early response in advanced colorectal cancer

Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation

Effects of molecular tumor board and different NGS panels implementation for the treatment of patients with cancer

Multidisciplinary molecular tumour board : a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer

Circulating tumor DNA detects early response to regorafenib in advanced colorectal cancer

High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib

Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor

Children's International Polyposis (CHIP) study : a randomized, double-blind, placebo-controlled study of celecoxib in children with familial adenomatous polyposis

Contents

Support

Contact